SIRT6 Antibody [Janelia Fluor® 549]
Novus Biologicals, part of Bio-Techne | Catalog # NB100-2523JF549
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Simple Western, Western Blot
Label
Janelia Fluor 549
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for SIRT6 Antibody [Janelia Fluor® 549]
Immunogen
A synthetic peptide made to an internal region of the human SIRT6 protein (within residues 250-350). [Swiss-Prot Q8N6T7]
Localization
Nuclear
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for SIRT6 Antibody [Janelia Fluor® 549]
Application
Recommended Usage
Simple Western
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: SIRT6
Long Name
NAD-dependent protein deacylase sirtuin-6
Alternate Names
EC 2.3.1.286, hSIRT6, SIR2-like protein 6, SIR2L6
Gene Symbol
SIRT6
Additional SIRT6 Products
Product Documents for SIRT6 Antibody [Janelia Fluor® 549]
Product Specific Notices for SIRT6 Antibody [Janelia Fluor® 549]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...